| Fiscal period | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Period End Date | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2011 |
|---|
| Revenues | 886.68 | 837.55 | 868.27 | 768.87 | 697.63 | 644.83 | 620.70 | 580.09 | 563.29 | 491.63 |
| Total Revenues | 886.68 | 837.55 | 868.27 | 768.87 | 697.63 | 644.83 | 620.70 | 580.09 | 563.29 | 491.63 |
| Cost of revenues | 359.15 | 327.27 | 346.87 | 314.68 | 276.12 | 264.06 | 242.15 | 227.18 | 225.28 | 193.18 |
| Gross Profit | 527.53 | 510.28 | 521.40 | 454.19 | 421.50 | 380.77 | 378.55 | 352.90 | 338.02 | 298.45 |
| Goodwill amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Amortization of deferred stock compensation | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research and development | 287.89 | 257.15 | 238.35 | 209.49 | 199.74 | 188.05 | 172.99 | 157.80 | 137.95 | 135.95 |
| In-process research and development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Write off of in-process research & development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, general and administrative | 201.34 | 196.44 | 197.84 | 159.73 | 155.48 | 160.49 | 154.15 | 130.80 | 114.39 | 112.42 |
| Impairment of goodwill and other intangible assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | 489.23 | 453.59 | 436.19 | 369.22 | 355.23 | 348.54 | 327.13 | 288.59 | 252.34 | 248.37 |
| Operating Income (Loss) | 38.30 | 56.70 | 85.21 | 84.97 | 66.28 | 32.23 | 51.42 | 64.31 | 85.68 | 50.07 |
| Interest expense | 34.14 | 20.23 | 19.69 | 14.13 | 2.59 | 2.83 | 3.15 | 3.29 | 1.15 | 0.04 |
| Interest income | 11.14 | 13.19 | 6.65 | 6.06 | 0.81 | 0.86 | 1.01 | 0.85 | 1.34 | 1.86 |
| Other income (expense), net | -- | -- | -- | -- | -- | -- | (0.23) | 0.16 | 0.48 | 0.44 |
| Income (loss) before income taxes | 15.30 | 49.65 | 72.16 | 76.90 | 64.50 | 30.26 | 49.04 | 62.03 | 86.35 | 52.34 |
| Current: Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Current: State | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Provision for income taxes | 2.77 | 30.38 | (11.43) | 29.81 | 3.00 | 0.68 | 11.02 | 12.21 | 22.80 | 16.87 |
| Deferred: Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred: State | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred: International | (2.49) | (10.62) | 0.50 | (0.45) | (1.63) | 2.54 | 0.70 | (2.27) | (0.72) | (0.38) |
| Current: Domestic | 1.49 | (0.78) | (8.84) | 48.95 | 2.64 | 0.95 | 7.08 | 4.80 | 21.08 | 14.47 |
| Deferred: Domestic | (4.03) | 33.62 | (8.98) | (25.76) | (2.43) | (5.83) | 2.35 | 5.59 | 5.44 | (0.07) |
| Current: International | 7.80 | 8.16 | 5.89 | 7.08 | 4.42 | 3.02 | 0.88 | 4.09 | (3.01) | 2.85 |
| Income (loss) from Continuing Operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income from discontinued operations, net of income taxes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (loss) Available to Common Shareholders | 12.53 | 19.27 | 83.59 | 47.09 | 61.49 | 29.59 | 38.02 | 49.82 | 63.55 | 35.47 |
| Continuing Operations- (Basic) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | 0.29 | 0.44 | 1.94 | 1.11 | 1.47 | 0.70 | 0.88 | 1.17 | 1.51 | 0.82 |
| Continuing Operations- (Diluted) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | 0.28 | 0.43 | 1.90 | 1.09 | 1.45 | 0.69 | 0.87 | 1.14 | 1.47 | 0.79 |
| Weighted Average Shares Outstanding (Basic) | 43.78 | 43.35 | 43.16 | 42.45 | 41.71 | 42.31 | 42.97 | 42.72 | 42.14 | 43.42 |
| Weighted Average Shares Outstanding (Diluted) | 44.37 | 44.29 | 44.04 | 43.33 | 42.38 | 42.95 | 43.79 | 43.54 | 43.11 | 44.83 |